2024-02-012025-01-312025-01-31false13166679HEALTH & YOU LIMITED2025-10-31falseiso4217:GBPxbrli:pure131666792024-01-31131666792025-01-31131666792024-02-012025-01-31131666792023-01-31131666792024-01-31131666792023-02-012024-01-3113166679bus:SmallEntities2024-02-012025-01-3113166679bus:AuditExempt-NoAccountantsReport2024-02-012025-01-3113166679bus:FullAccounts2024-02-012025-01-3113166679bus:PrivateLimitedCompanyLtd2024-02-012025-01-3113166679core:WithinOneYear2025-01-3113166679core:AfterOneYear2025-01-3113166679core:WithinOneYear2024-01-3113166679core:AfterOneYear2024-01-3113166679core:ShareCapital2025-01-3113166679core:SharePremium2025-01-3113166679core:RevaluationReserve2025-01-3113166679core:OtherReservesSubtotal2025-01-3113166679core:RetainedEarningsAccumulatedLosses2025-01-3113166679core:ShareCapital2024-01-3113166679core:SharePremium2024-01-3113166679core:RevaluationReserve2024-01-3113166679core:OtherReservesSubtotal2024-01-3113166679core:RetainedEarningsAccumulatedLosses2024-01-3113166679core:LandBuildings2025-01-3113166679core:PlantMachinery2025-01-3113166679core:Vehicles2025-01-3113166679core:FurnitureFittings2025-01-3113166679core:OfficeEquipment2025-01-3113166679core:NetGoodwill2025-01-3113166679core:IntangibleAssetsOtherThanGoodwill2025-01-3113166679core:ListedExchangeTraded2025-01-3113166679core:UnlistedNon-exchangeTraded2025-01-3113166679core:LandBuildings2024-01-3113166679core:PlantMachinery2024-01-3113166679core:Vehicles2024-01-3113166679core:FurnitureFittings2024-01-3113166679core:OfficeEquipment2024-01-3113166679core:NetGoodwill2024-01-3113166679core:IntangibleAssetsOtherThanGoodwill2024-01-3113166679core:ListedExchangeTraded2024-01-3113166679core:UnlistedNon-exchangeTraded2024-01-3113166679core:LandBuildings2024-02-012025-01-3113166679core:PlantMachinery2024-02-012025-01-3113166679core:Vehicles2024-02-012025-01-3113166679core:FurnitureFittings2024-02-012025-01-3113166679core:OfficeEquipment2024-02-012025-01-3113166679core:NetGoodwill2024-02-012025-01-3113166679core:IntangibleAssetsOtherThanGoodwill2024-02-012025-01-3113166679core:ListedExchangeTraded2024-02-012025-01-3113166679core:UnlistedNon-exchangeTraded2024-02-012025-01-3113166679core:MoreThanFiveYears2024-02-012025-01-3113166679core:Non-currentFinancialInstruments2025-01-3113166679core:Non-currentFinancialInstruments2024-01-3113166679dpl:CostSales2024-02-012025-01-3113166679dpl:DistributionCosts2024-02-012025-01-3113166679core:LandBuildings2024-02-012025-01-3113166679core:PlantMachinery2024-02-012025-01-3113166679core:Vehicles2024-02-012025-01-3113166679core:FurnitureFittings2024-02-012025-01-3113166679core:OfficeEquipment2024-02-012025-01-3113166679dpl:AdministrativeExpenses2024-02-012025-01-3113166679core:NetGoodwill2024-02-012025-01-3113166679core:IntangibleAssetsOtherThanGoodwill2024-02-012025-01-3113166679dpl:GroupUndertakings2024-02-012025-01-3113166679dpl:ParticipatingInterests2024-02-012025-01-3113166679dpl:GroupUndertakingscore:ListedExchangeTraded2024-02-012025-01-3113166679core:ListedExchangeTraded2024-02-012025-01-3113166679dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-02-012025-01-3113166679core:UnlistedNon-exchangeTraded2024-02-012025-01-3113166679dpl:CostSales2023-02-012024-01-3113166679dpl:DistributionCosts2023-02-012024-01-3113166679core:LandBuildings2023-02-012024-01-3113166679core:PlantMachinery2023-02-012024-01-3113166679core:Vehicles2023-02-012024-01-3113166679core:FurnitureFittings2023-02-012024-01-3113166679core:OfficeEquipment2023-02-012024-01-3113166679dpl:AdministrativeExpenses2023-02-012024-01-3113166679core:NetGoodwill2023-02-012024-01-3113166679core:IntangibleAssetsOtherThanGoodwill2023-02-012024-01-3113166679dpl:GroupUndertakings2023-02-012024-01-3113166679dpl:ParticipatingInterests2023-02-012024-01-3113166679dpl:GroupUndertakingscore:ListedExchangeTraded2023-02-012024-01-3113166679core:ListedExchangeTraded2023-02-012024-01-3113166679dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-02-012024-01-3113166679core:UnlistedNon-exchangeTraded2023-02-012024-01-3113166679core:NetGoodwill2025-01-3113166679core:IntangibleAssetsOtherThanGoodwill2025-01-3113166679core:LandBuildings2025-01-3113166679core:PlantMachinery2025-01-3113166679core:Vehicles2025-01-3113166679core:FurnitureFittings2025-01-3113166679core:OfficeEquipment2025-01-3113166679core:AfterOneYear2025-01-3113166679core:WithinOneYear2025-01-3113166679core:ListedExchangeTraded2025-01-3113166679core:UnlistedNon-exchangeTraded2025-01-3113166679core:ShareCapital2025-01-3113166679core:SharePremium2025-01-3113166679core:RevaluationReserve2025-01-3113166679core:OtherReservesSubtotal2025-01-3113166679core:RetainedEarningsAccumulatedLosses2025-01-3113166679core:NetGoodwill2024-01-3113166679core:IntangibleAssetsOtherThanGoodwill2024-01-3113166679core:LandBuildings2024-01-3113166679core:PlantMachinery2024-01-3113166679core:Vehicles2024-01-3113166679core:FurnitureFittings2024-01-3113166679core:OfficeEquipment2024-01-3113166679core:AfterOneYear2024-01-3113166679core:WithinOneYear2024-01-3113166679core:ListedExchangeTraded2024-01-3113166679core:UnlistedNon-exchangeTraded2024-01-3113166679core:ShareCapital2024-01-3113166679core:SharePremium2024-01-3113166679core:RevaluationReserve2024-01-3113166679core:OtherReservesSubtotal2024-01-3113166679core:RetainedEarningsAccumulatedLosses2024-01-3113166679core:NetGoodwill2023-01-3113166679core:IntangibleAssetsOtherThanGoodwill2023-01-3113166679core:LandBuildings2023-01-3113166679core:PlantMachinery2023-01-3113166679core:Vehicles2023-01-3113166679core:FurnitureFittings2023-01-3113166679core:OfficeEquipment2023-01-3113166679core:AfterOneYear2023-01-3113166679core:WithinOneYear2023-01-3113166679core:ListedExchangeTraded2023-01-3113166679core:UnlistedNon-exchangeTraded2023-01-3113166679core:ShareCapital2023-01-3113166679core:SharePremium2023-01-3113166679core:RevaluationReserve2023-01-3113166679core:OtherReservesSubtotal2023-01-3113166679core:RetainedEarningsAccumulatedLosses2023-01-3113166679core:AfterOneYear2024-02-012025-01-3113166679core:WithinOneYear2024-02-012025-01-3113166679core:Non-currentFinancialInstrumentscore:CostValuation2024-02-012025-01-3113166679core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-012025-01-3113166679core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-012025-01-3113166679core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-012025-01-3113166679core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-012025-01-3113166679core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-012025-01-3113166679core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-012025-01-3113166679core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-012025-01-3113166679core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-012025-01-3113166679core:Non-currentFinancialInstrumentscore:CostValuation2025-01-3113166679core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-3113166679core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-3113166679core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-3113166679core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-3113166679core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-3113166679core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-3113166679core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-3113166679core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-3113166679core:Non-currentFinancialInstrumentscore:CostValuation2024-01-3113166679core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-3113166679core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-3113166679core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-3113166679core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-3113166679core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-3113166679core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-3113166679core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-3113166679core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-3113166679bus:Director12024-02-012025-01-31

HEALTH & YOU LIMITED

Registered Number
13166679
(England and Wales)

Unaudited Financial Statements for the Year ended
31 January 2025

HEALTH & YOU LIMITED
Company Information
for the year from 1 February 2024 to 31 January 2025

Director

Mr Anoushiravan Ariakish

Company Secretary

Mrs Sogol Ariakish

Registered Address

10 West Hampstead Mews
London
NW6 3BB

Registered Number

13166679 (England and Wales)
HEALTH & YOU LIMITED
Balance Sheet as at
31 January 2025

Notes

2025

2024

£

£

£

£

Current assets
Debtors3189,421182,831
189,421182,831
Creditors amounts falling due within one year4(125,838)(132,520)
Net current assets (liabilities)63,58350,311
Total assets less current liabilities63,58350,311
Net assets63,58350,311
Capital and reserves
Called up share capital44
Profit and loss account63,57950,307
Shareholders' funds63,58350,311
The financial statements were approved and authorised for issue by the Director on 31 October 2025, and are signed on its behalf by:
Mr Anoushiravan Ariakish
Director
Registered Company No. 13166679
HEALTH & YOU LIMITED
Notes to the Financial Statements
for the year ended 31 January 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number is 13166679 and registered office address is 10 West Hampstead Mews, London, England, NW6 3BB.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable and net of discounts. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financial transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised. Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
2.Average number of employees

20252024
Average number of employees during the year11
3.Debtors: amounts due within one year

2025

2024

££
Other debtors189,421182,831
Total189,421182,831
At the balance sheet date, other debtors balance comprised the following: Intercompany loan- White Rose Dental: £189,417 Called up share capital not paid: £4
4.Creditors: amounts due within one year

2025

2024

££
Bank borrowings and overdrafts112,268117,720
Taxation and social security12,55012,751
Accrued liabilities and deferred income1,0202,049
Total125,838132,520
At the balance sheet date, other creditors balance comprised the following: Directors' loan: £107,606 Accruals: £1,020
5.Share capital
Authorised share capital: The company has authorised ordinary shares as follows Ordinary Shares:4 @ £1 each, unpaid. As of 31 March 2025, the total ordinary share capital remains at £4, consistent with the previous year.
6.Related party transactions
Health and You Limited owes £189,417 to the intercompany- White Rose Dental Practice as at 31st Jan 2025 (2024: £181,831).